Protein tyrosine phosphatase-1B contributes to LPS-induced leptin resistance in male rats

• Published in: American journal of physiology: endocrinology and metabolism 2015-01, Vol.308 (1), p.E40-E50
• Main Authors: Borges, Beatriz de Carvalho, Rorato, Rodrigo C, Uchoa, Ernane Torres, Marangon, Paula B, Elias, Carol F, Antunes-Rodrigues, Jose, Elias, Lucila L K
• Format: Article
• Language: English
• Subjects: Animals; Brain; Drug Resistance - drug effects; Drug Resistance - genetics; Hormones; Hypothalamus - drug effects; Hypothalamus - metabolism; Inflammation - metabolism; Leptin - metabolism; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Obesity; Obesity - genetics; Obesity - metabolism; Physiology; Protein expression; Protein Tyrosine Phosphatase, Non-Receptor Type 1 - physiology; Proteins; Rats; Rats, Wistar; Receptors, Leptin - genetics; Receptors, Leptin - metabolism
• ISSN: 0193-1849; 1522-1555
• DOI: 10.1152/ajpendo.00094.2014

Leptin resistance is induced by the feedback inhibitors tyrosine phosphatase-1B (PTP1B) and decreased Src homology 2 domain-containing tyrosine phosphatase-2 (SHP-2) signaling. To investigate the participation of PTP1B and SHP-2 in LPS-induced leptin resistance, we injected repeated (6-LPS) intraperitoneal LPS doses (100 μg/kg ip) for comparison with a single (1-LPS) treatment and evaluated the expression of SHP-2, PTP1B, p-ERK1/2, and p-STAT3 in the hypothalamus of male Wistar rats. The single LPS treatment increased the expression of p-STAT3 and PTP1B but not SHP-2. The repeated LPS treatment reduced SHP-2, increased PTP1B, and did not change p-STAT3. We observed that the PTP1B expression induced by the endotoxin was highly colocalized with leptin receptor cells in the hypothalamus of LepRb-IRES-Cre-tdTomato reporter mice. The single, but not the repeated, LPS treatment decreased the food intake and body weight. Leptin had no stimulatory effect on the hypophagia, body weight loss, or pSTAT3 expression in 6-LPS rats, indicating leptin unresponsiveness. Notably, the PTP1B inhibitor (3.0 nmol/rat in 5 μl icv) restored the LPS-induced hypophagia in 6-LPS rats and restored the ability of leptin to reduce food intake and body weight as well as to phosphorylate STAT3 in the arcuate, paraventricular, and ventromedial nuclei of the hypothalamus. The present data suggest that an increased PTP1B expression in the hypothalamus underlies the development of leptin resistance during repeated exposure to LPS. Our findings contribute to understanding the mechanisms involved in leptin resistance during low-grade inflammation as seen in obesity.